Search:
   

Friday, April 17, 2026

Equity Corporate Actions Alert #2026 - 255
Information regarding the ADR to Ordinary conversion for Ascendis Pharma A/S (ASND)

Category:

  • Industry Announcement

Markets Impacted:

Contact Information:

  • Nasdaq Corporate Data Operations at +1 877 308 0523
  • Nasdaq Trading Services at +1 212 231 5100

Resources:

Ascendis Pharma A/S (ASND) announced the termination of its ADR program resulting in a conversion of American Depositary Receipts to Ordinary Shares along with a CUSIP# change. For every One (1) ADS held shareholders will receive one (1) Ordinary Share. The details are as follows:

Company: Ascendis Pharma A/S
Current Issue Type: American Depositary Shares
New Issue Type: Ordinary Shares
Current CUSIP: 04351P101
New CUSIP: K08588103
Symbol: ASND
Ratio of Exchange:
 One (1) Ordinary share for every One (1) ADS held
Effective Date: April 20, 2026

For information regarding this announcement, contact Nasdaq Corporate Data Operations at +1 877 308 0523.

If you would like to register as a market maker in ASND contact Nasdaq Trading Services at +1 212 231 5100.